These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 5545123)

  • 21. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG; Ward PA; Torikata T
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A leukotactic factor in the stratum corneum of pustulosis palmaris et plantaris: a possible mechanism for the formation of intra-epidermal sterile pustules.
    Tagami H; Ofuji S
    Acta Derm Venereol; 1978; 58(5):401-5. PubMed ID: 82349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the third component of complement in synovial fluid from arthritic patients.
    Lundh B; Hedberg H; Laurell AB
    Clin Exp Immunol; 1970 Mar; 6(3):407-11. PubMed ID: 5442523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    Becker EL
    J Exp Med; 1972 Feb; 135(2):376-87. PubMed ID: 4551218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis.
    Moxley G; Ruddy S
    Arthritis Rheum; 1985 Oct; 28(10):1089-95. PubMed ID: 3876836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotactic activity in the fluid of bullous pemphigoid blisters].
    Diáz Pérez JL; Jordon RE
    Med Cutan Ibero Lat Am; 1975; 3(6):465-70. PubMed ID: 778510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further studies on the C5-derived chemotactic factor for tumor cells.
    Romualdez AG; Ward PA
    Prog Clin Biol Res; 1976; 9():65-71. PubMed ID: 193134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].
    Peltier AP; Vial MC; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):959-67. PubMed ID: 4921319
    [No Abstract]   [Full Text] [Related]  

  • 30. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.
    Lachmann PJ; Kay AB; Thompson RA
    Immunology; 1970 Dec; 19(6):895-9. PubMed ID: 5487541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research on non-hemolytic (immuno-adherent) complement and on the 3d component of complement (C'3) in the synovial liquid during inflammatory rheumatism].
    Peltier AP
    Rev Fr Etud Clin Biol; 1968 Apr; 13(4):351-9. PubMed ID: 5682745
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
    Nakayama M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of synovial fluid total hemolytic complement activity.
    Kim HJ; McCarty DJ; Kozin F; Koethe S
    J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.
    Jose PJ; Moss IK; Maini RN; Williams TJ
    Ann Rheum Dis; 1990 Oct; 49(10):747-52. PubMed ID: 2241262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
    Stanczyk J; Kowalski ML; Grzegorczyk J; Szkudlinska B; Jarzebska M; Marciniak M; Synder M
    Mediators Inflamm; 2005 Dec; 2005(6):343-8. PubMed ID: 16489254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on hemolytic complement in synovial fluids.
    Zvaifler NJ
    Univ Mich Med Cent J; 1968; ():234-7. PubMed ID: 5728243
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis.
    de Ceulaer C; Papazoglou S; Whaley K
    Immunology; 1980 Sep; 41(1):37-43. PubMed ID: 6903558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.
    Perez HD; Horn JK; Ong R; Goldstein IM
    J Lab Clin Med; 1983 Jan; 101(1):123-9. PubMed ID: 6848611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A; Whaley K
    J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.